rise in diabetic population is driving the Blood Glucose Monitoring Market in APAC
Technavio analyzes that the Blood Glucose Monitoring Market in APAC is expected to grow at a CAGR of 8.5% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1508.1 million.There are various factors that contribute to the growth of the market. The Blood Glucose Monitoring market in the Asia-Pacific region is experiencing significant growth due to the increasing diabetic population. According to the International Diabetes Federation, the region is home to over 150 million diabetics, with numbers projected to rise. This surge in diabetes prevalence is driving the demand for advanced and accurate blood glucose monitoring devices and solutions. The market is expected to continue expanding as awareness and accessibility improve, providing essential tools for effective diabetes management.
The Small Molecule Blood Glucose Monitoring (SMBG) market in the Asia Pacific (APAC) region is poised for substantial growth due to the escalating prevalence of diabetes and related complications. With India and China leading the world in diabetic populations, the number of diabetes cases is projected to surge in these countries over the forecast period. Patients in APAC predominantly prefer SMBGs for their convenience, portability, accuracy, and low power consumption. Vendors catering to this market offer advanced, safe, and innovative SMBG devices to address the rising demand. Symptoms such as vision problems, poor blood flow, kidney disease, and low blood sugar, among others, necessitate regular glucose monitoring. As a result, the market is anticipated to experience significant growth, driven by the increasing incidence of diabetes and the availability of sophisticated SMBG devices.
Know which region is leading the market growth by requesting a sample report
Blood Glucose Monitoring Market in APAC Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
In the APAC region, the market for blood glucose monitoring solutions encompasses various devices such as blood glucose meters and glucometers. These devices enable users to test their blood sugar levels using a finger-stick method with a lancet and testing strips. Pre-testing procedures include cleaning the site with an alcohol swab for infection prevention. The monitors feature a digital display to show the blood sugar range, and post-testing involves applying a bandage and following nutritional snack ideas, medication dosages, exercise, and diet recommendations. Proper management is crucial for individuals with diabetes, as high blood sugar levels can lead to complications such as heart disease, nerve damage, vision problems, poor blood flow, and kidney disease. Low blood sugar symptoms include confusion and weakness. Both Type 1 and Type 2 diabetes patients benefit from regular monitoring.
The Blood Glucose Monitoring Market in APAC is a significant segment of the global Healthcare Equipment Market, focusing on the production and sales of glucometers, testing strips, lancets, alcohol swabs, bandages, and other related accessories. These devices are instrumental in monitoring and managing blood sugar levels for individuals with diabetes. Technavio, a leading global technology research and consulting firm, classifies this market as part of the broader healthcare equipment industry. The healthcare equipment market encompasses various product categories, including capital equipment, instruments, implants, accessories, and consumables, used for disease diagnosis, monitoring, and treatment. The market size for the healthcare equipment industry is determined by the combined revenue generated by manufacturers of diagnostic equipment and devices across diverse therapy areas. In the context of the Blood Glucose Monitoring Market in APAC, key players include Roche Diagnostics, Abbott Laboratories, and Johnson & Johnson. These companies invest heavily in R&D to develop advanced, differentiated, and clinically tested devices to meet the growing demand for accurate and efficient blood glucose monitoring solutions.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted